ZIMMER BIOMET HOLDINGS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Income (Loss) from Continuing Operations, Per Diluted Share of $4.43 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2025-02-25
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-09-30 was $0.77, a 16.30% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-06-30 was $1.00, a 36.99% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-03-31 was $1.11, a 217.14% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2022-09-30 was $0.92, a 19.48% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was $4.43, a 9.22% decline from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was $4.88, a 253.62% increase from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was $1.38.
- ZIMMER BIOMET HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2020 was -$0.05.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2024-12-31 | $4.43 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $4.88 10-K · filed 2025-02-25 | |||
| 2023-09-30 | $0.77 10-Q · filed 2023-11-07 | $2.88 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $1.00 10-Q · filed 2023-08-01 | $2.10 10-Q · filed 2023-08-01 | ||
| 2023-03-31 | $1.11 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $1.38 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $0.92 10-Q · filed 2023-11-07 | $2.00 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.73 10-Q · filed 2023-08-01 | $1.08 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | $0.35 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $2.12 8-K · filed 2024-08-07 | |||
| 2021-09-30 | $0.77 10-Q · filed 2022-11-02 | $2.37 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.68 10-Q · filed 2022-08-02 | $1.61 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $0.92 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$0.05 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $5.41 8-K · filed 2022-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |